Differences in drug metabolism polymorphism between Orientals and Caucasians (Q37783192)

23 August 2017

1 reference

title

Differences in drug metabolism polymorphism between Orientals and Caucasians (English)

1 reference

23 August 2017

Lou YC

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

23 August 2017

published in

Drug Metabolism Reviews

1 reference

23 August 2017

volume

22

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

451-475

1 reference

23 August 2017

cites work

Human cytochromes P-450.

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Evidence for polymorphic oxidation of sparteine in Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Polymorphic metabolism of metoprolol: clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

S-mephenytoin 4-hydroxylase is inherited as an autosomal-recessive trait in Japanese families

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Diazepam disposition determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Pharmacogenetic study with diazepam in twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Diazepam effects and kinetics in Caucasians and Orientals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Differences in diazepam pharmacokinetics in Chinese and white Caucasians--relation to body lipid stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Studies on the subunit structure and molecular size of the human alcohol dehydrogenase isozymes determined by the different loci, ADH1ADH2, and ADH3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Human liver alcohol dehydrogenase: the unique properties of the "atypical" isoenzyme beta 2 beta 2-Bern can be explained by a single base mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

N-acetylation phenotyping with dapsone in a mainland Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Disease and Acetylation Polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Significance of the acetylation phenotype and the therapeutic effect of procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Acetylator phenotype and lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

A simple test for acetylator phenotype using caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602539008991447

10.3109/03602539008991447

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference